InCarda Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- April 28, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $5,000,000
Company Info
- Founders
- Grace E. Colon
- Company Description
- Incarda Therapeutics offers a novel approach to treat cardiovascular conditions and diseases by the inhalation route.
- Market
- Cardiovascular Disease Treatment
- Location
- San Francisco, CA, USA
- Coinvestors
- Morningside Technology Advisory